Amanote Research

Amanote Research

    RegisterSign In

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology - United Kingdom
doi 10.1002/hon.223_2631
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncologyHematology
Date

June 1, 2019

Authors
A.K. HerbrandA.M. SchmittM. JoergerL.G. HemkensB. Kasenda
Publisher

Wiley


Related search

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia
Dermatology
2013English

Off-Label Use of Anticancer Drugs in South Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Trends in Off-Label Drug Use in Ambulatory Settings: 2006–2015

Pediatrics
Child HealthPediatricsPerinatology
2019English

Off-Label Use of Clonidine for Sedation in Dutch ICUs

Critical Care
Critical CareIntensive Care Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy